Response Evaluation of Chemotherapy for Lung Cancer
Ki-Eun Hwang, Hak-Ryul Kim
Tuberc Respir Dis. 2017;80(2):136-142.   Published online 2017 Mar 31     DOI: https://doi.org/10.4046/trd.2017.80.2.136
Citations to this article as recorded by Crossref logo
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan
Thomas Muley, Mark A. Schneider, Michael Meister, Michael Thomas, Claus Peter Heußel, Mark Kriegsmann, Stefan Holdenrieder, Birgit Wehnl, Vinzent Rolny, Anika Mang, Rebecca Gerber, Felix Herth, Stefan Holdenrieder, Huub van Rossum, Michel van den Heuvel
Tumor Biology.2024; 46(s1): S163.     CrossRef
New Targeted Therapy for Non-Small Cell Lung Cancer
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee
Tuberculosis and Respiratory Diseases.2023; 86(1): 1.     CrossRef
Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review
David J. Murphy, Maria Mayoral, Anna R. Larici, Michelle S. Ginsberg, Giuseppe Cicchetti, Florian J. Fintelmann, Edith M. Marom, Mylene T. Truong, Ritu R. Gill
American Journal of Roentgenology.2023; 221(4): 409.     CrossRef
PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features of Lung Adenocarcinomas in Cytological Samples
Sarah A. Anderson, Djamel Harbi, Diana Oramas Mogrovejo, Antoinette D. Floyd, Isam-Eldin Eltoum, Huma Fatima, Frida Rosenblum, Manuel Lora Gonzalez, Diana Lin, Alexander C. Mackinnon, Gene P. Siegal, Thomas Winokur, Ceren Yalniz, Lei Huo, Shuko Harada, X
Acta Cytologica.2023; 67(5): 507.     CrossRef
Use of amantadine in the evaluation of response to chemotherapy in lung cancer: a pilot study
Andrew W Maksymiuk, Paramjit S Tappia, Rashid Ahmed Bux, Dante Moyer, Guoyu Huang, Philippe Joubert, Donald W Miller, Bram Ramjiawan, Daniel S Sitar
Future Science OA.2021;[Epub]     CrossRef
A Model-Strengthened Imaging Biomarker for Survival Prediction in EGFR-Mutated Non-small-cell Lung Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Annabelle Collin, Vladimir Groza, Louise Missenard, François Chomy, Thierry Colin, Jean Palussière, Olivier Saut
Bulletin of Mathematical Biology.2021;[Epub]     CrossRef
Sintilimab plus Bronchial Arterial Infusion Chemotherapy/Drug-Eluting Embolic Chemoembolization for Advanced Non–Small Cell Lung Cancer: A Preliminary Study of 10 Patients
Yuan-Ming Li, Run-Qi Guo, Zhi-Xin Bie, Bin Li, Xiao-Guang Li
Journal of Vascular and Interventional Radiology.2021; 32(12): 1679.     CrossRef
Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
In Kyoung Hwang, Seung Sook Paik, Seung Hyeun Lee
Cancer Research and Treatment.2019; 51(1): 158.     CrossRef
Effects of BENC-511, a novel PI3K inhibitor, on the proliferation and apoptosis of A549 human lung adenocarcinoma cells
Huiqin Tian, Yu Zhang, Qianyun Zhang, Shuixian Li, Yang Liu, Xiuzhen Han
BioScience Trends.2019; 13(1): 40.     CrossRef
Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
Seung Sook Paik, In Kyoung Hwang, Myung Jae Park, Seung Hyeun Lee
Tuberculosis and Respiratory Diseases.2018; 81(2): 148.     CrossRef
Qiyusanlong decoction suppresses lung cancer in mice via Wnt/β-catenin pathway
Jia‑Bing Tong, Xing‑Xing Zhang, Xin‑Heng Wang, Shi‑Jie Zeng, Dan‑Yang Wang, Zhi‑Qiang Zhang, Jian Hu, Chen Yang, Ze‑Geng Li
Molecular Medicine Reports.2018;[Epub]     CrossRef